SE0100823D0 - Method I to obtain microparticles - Google Patents

Method I to obtain microparticles

Info

Publication number
SE0100823D0
SE0100823D0 SE0100823A SE0100823A SE0100823D0 SE 0100823 D0 SE0100823 D0 SE 0100823D0 SE 0100823 A SE0100823 A SE 0100823A SE 0100823 A SE0100823 A SE 0100823A SE 0100823 D0 SE0100823 D0 SE 0100823D0
Authority
SE
Sweden
Prior art keywords
polymer
atpase inhibitor
obtain microparticles
atomized
droplets
Prior art date
Application number
SE0100823A
Other languages
English (en)
Swedish (sv)
Inventor
Brita Sjoeblom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0100823A priority Critical patent/SE0100823D0/xx
Publication of SE0100823D0 publication Critical patent/SE0100823D0/xx
Priority to AU2002235100A priority patent/AU2002235100B8/en
Priority to PCT/SE2002/000399 priority patent/WO2002072070A1/en
Priority to US10/469,888 priority patent/US20040131689A1/en
Priority to JP2002571029A priority patent/JP2004527505A/ja
Priority to EP02701871A priority patent/EP1370242A1/en
Priority to NZ527996A priority patent/NZ527996A/en
Priority to CA002440158A priority patent/CA2440158A1/en
Priority to CNA028096088A priority patent/CN1507344A/zh
Priority to US11/339,206 priority patent/US20060159756A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0100823A 1999-09-10 2001-03-09 Method I to obtain microparticles SE0100823D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0100823A SE0100823D0 (sv) 2001-03-09 2001-03-09 Method I to obtain microparticles
AU2002235100A AU2002235100B8 (en) 2001-03-09 2002-03-06 Method to obtain microparticles containing A H+, K+ -ATP-ase inhibitor
PCT/SE2002/000399 WO2002072070A1 (en) 2001-03-09 2002-03-06 Method to obtain microparticles containing a h+, k+-atp-ase inhibitor
US10/469,888 US20040131689A1 (en) 2001-03-09 2002-03-06 Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor
JP2002571029A JP2004527505A (ja) 2001-03-09 2002-03-06 Ｈ＋，ｋ＋−ａｔｐアーゼ阻害剤を含む微粒子の製造方法
EP02701871A EP1370242A1 (en) 2001-03-09 2002-03-06 Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor
NZ527996A NZ527996A (en) 2001-03-09 2002-03-06 Method to obtain microparticles containing a H+, K+-ATP-ase inhibitor
CA002440158A CA2440158A1 (en) 2001-03-09 2002-03-06 Method to obtain microparticles containing a h+, k+-atp-ase inhibitor
CNA028096088A CN1507344A (zh) 2001-03-09 2002-03-06 获得含h+,k+－atp酶抑制剂的微粒的方法
US11/339,206 US20060159756A1 (en) 1999-09-10 2006-01-25 Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100823A SE0100823D0 (sv) 2001-03-09 2001-03-09 Method I to obtain microparticles

Publications (1)

Publication Number Publication Date
SE0100823D0 true SE0100823D0 (sv) 2001-03-09

Family

ID=20283294

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100823A SE0100823D0 (sv) 1999-09-10 2001-03-09 Method I to obtain microparticles

Country Status (9)

Country Link
US (1) US20040131689A1 (https=)
EP (1) EP1370242A1 (https=)
JP (1) JP2004527505A (https=)
CN (1) CN1507344A (https=)
AU (1) AU2002235100B8 (https=)
CA (1) CA2440158A1 (https=)
NZ (1) NZ527996A (https=)
SE (1) SE0100823D0 (https=)
WO (1) WO2002072070A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
US6869617B2 (en) 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
SE0100824D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method III to obtain microparticles
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
JP2005504090A (ja) 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
WO2005072702A2 (en) * 2004-01-20 2005-08-11 Alkermes Controlled Therapeutics, Inc. Method for milling frozen microparticles
DE102005001162A1 (de) * 2005-01-10 2006-07-20 Haemosys Gmbh Adsorptionssystem zur Entfernung von Viren und viralen Bestandteilen aus Flüssigkeiten, insbesondere aus Blut und Blutplasma
WO2007056205A2 (en) * 2005-11-04 2007-05-18 Eastman Chemical Company Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
WO2007122478A2 (en) * 2006-04-20 2007-11-01 Themis Laboratories Private Limited Multiple unit compositions
GB0707612D0 (en) 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
CN102512382B (zh) * 2011-12-23 2013-09-04 天津市汉康医药生物技术有限公司 供注射用埃索美拉唑钠药物组合物
DE102019133243A1 (de) * 2019-12-05 2021-06-10 Rheinische Friedrich-Wilhelms-Universität Bonn Verfahren zur Herstellung sprühgefriergetrockneter Partikel und entsprechend hergestellte Partikel
JP2023151957A (ja) * 2022-04-01 2023-10-16 理研ビタミン株式会社 薬物含有粒子の製造方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
US3721725A (en) * 1970-08-14 1973-03-20 Du Pont Process for preparing powder blends
US4526734A (en) * 1981-03-05 1985-07-02 Ibigawa Electric Industry Co., Ltd. Process for the production of silicon carbide sintered bodies
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
US5017383A (en) * 1989-08-22 1991-05-21 Taisho Pharmaceutical Co., Ltd. Method of producing fine coated pharmaceutical preparation
US5102983A (en) * 1990-04-02 1992-04-07 United States Surgical Corporation Process for preparing foamed, bioabsorbable polymer particles
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
EE03305B1 (et) * 1994-07-08 2000-12-15 Astra Aktiebolag Paljuosaline tableteeritud annusvorm I
GB2329124B (en) * 1997-09-12 2002-05-08 Hiran Asoka Malinga Ratwatte Method of forming dose units of active agents
CA2376202C (en) * 1999-06-07 2008-11-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel preparation and administration form comprising an acid-labile active compound
SE9903236D0 (sv) * 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles
SE0100824D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method III to obtain microparticles
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles

Also Published As

Publication number Publication date
NZ527996A (en) 2005-02-25
CA2440158A1 (en) 2002-09-19
CN1507344A (zh) 2004-06-23
AU2002235100B8 (en) 2006-08-31
JP2004527505A (ja) 2004-09-09
EP1370242A1 (en) 2003-12-17
WO2002072070A1 (en) 2002-09-19
US20040131689A1 (en) 2004-07-08
AU2002235100B2 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
SE0100823D0 (sv) Method I to obtain microparticles
ATE245022T1 (de) Verfahren zur herstellung von mikropartikeln
BR0214279A (pt) Composições farmacêuticas em forma particulada
WO2002049590A3 (en) Antiperspirant products
MXPA05007154A (es) Atomizador prepeliculizacion.
WO2006044334A3 (en) Platelet-derived growth factor compositions and methods of use thereof
WO2002099027A3 (en) Solid cleaning composition including stabilized active oxygen component
BR0204804A (pt) Agente estabilizante de proteìnas para a estabilização de um material protéico em meio ácido aquoso, composição para suspensão em um lìquido ácido aquoso, método de estabilização de proteìnas em um lìquido ácido aquoso e método de formação de uma suspensão estável de material protéico em sucos ácidos
WO2003002109A8 (en) Use of tyrosine kinase inhibitors for treating autoimmune diseases
TW200731372A (en) Substrate cleaning method and apparatus and computer readable storage medium
ATE306917T1 (de) Pharmazeutische zusammensetzung mit 2-(4- isobutylphenyl) propionsäure
MXPA03007887A (es) Metodo para obtener microparticulas que contienen inhibidor de h(+), k(+)-atp-asa.
DE60312033D1 (de) Verfahren zur verringerung der bitterkeit von aminosäure
MXPA03010217A (es) Composicion para el cuidado de la piel.
ATE287255T1 (de) Stabile flüssigkeiten mit hohem glycerolgehalt, die sulfosuccinsäuremonoester enthalten
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
AU2001293552A1 (en) Cleaning formulation and method of cleaning a surface
GB2392466A (en) Well service fluid and method of making and using the same
WO2000011039A3 (en) Free radical inhibitors for quenching aqueous phase polymer growth and related methods
GB2387101A (en) Compositions containing creatine and creatinine
DK0824575T3 (da) Miljøvenlig sne- og isopløsende væske
WO2004095921A3 (en) Sporicidal composition
EP1260527A3 (en) Acrylic acid (salt) polymer, its production process and uses
EP1618883A4 (en) MEANS TO PREVENT AND PREVENT OBSTIPATION
ATE401797T1 (de) Anorganische partikel enthaltende zusatzstoffzusammensetzung, verfahren zu ihrer herstellung und die zusatzstoffzusammensetzung enthaltendes nahrungsmittelprodukt